A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 33/00 (2006.01) A61K 31/131 (2006.01) A61K 31/155 (2006.01) A61K 31/195 (2006.01) A61K 31/198 (2006.01) A61K 31/21 (2006.01) A61K 31/295 (2006.01) A61K 31/519 (2006.01) A61K 45/06 (2006.01) A61M 15/00 (2006.01) A61M 16/10 (2006.01)
Patent
CA 2097823
A method for treating or preventing bronchoconstriction or reversible pulmonary vasoconstriction in a mammal, which method includes causing the mammal to inhale a therapeutically-effective concentration of gaseous nitric oxide (1,10) or a therapeutically-effective amount of a nitric oxide-releasing compound (106) and an inhaler device (102) containing nitric oxide gas and/or a nitric oxide-releasing compound.
Procédé destiné au traitement ou à la prévention de la bronchoconstriction ou de la vasoconstriction pulmonaire réversible chez un mammifère, et qui consiste à faire respirer au patient une concentration efficace d'un point de vue thérapeutique d'un oxyde nitrique gazeux (1, 10) ou une quantité efficace d'un point de vue thérapeutique d'un composé libérant l'oxyde nitrique (106). Le procédé comprend un dispositif d'inhalation (102) contenant un gaz d'oxyde nitrique et/ou un composé libérant l'oxyde nitrique.
Frostell Claes
Zapol Warren M.
Kirby Eades Gale Baker
The General Hospital Corporation
LandOfFree
Therapy for pulmonary vasoconstriction and asthma does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Therapy for pulmonary vasoconstriction and asthma, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapy for pulmonary vasoconstriction and asthma will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1377418